From: Gender equity and COVID-19 vaccine policies for pregnant people: a global analysis
 | 6/1/2021 | 10/15/2021 | 3/1/2022 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | n | cOR | 95%CI | p-val | n | cOR | 95%CI | p-val | n | cOR | 95%CI | p-val |
GGGI | 114 | 0.92 | 0.87, 0.98 | 0.013 | 137 | 0.87 | 0.80, 0.95 | 0.001 | 142 | 0.84 | 0.75, 0.94 | 0.003 |
mRNA vaccine | 146 | 0.34 | 0.17, 0.67 | 0.002 | 188 | 0.28 | 0.12, 0.67 | 0.004 | 198 | 0.79 | 0.23, 2.68 | 0.703 |
Income level | ||||||||||||
 Low | 4 | 2.80 | 0.37, 21.22 | 0.319 | 11 | 17.29 | 3.66, 81.80 | 0.000 | 16 | 6.54 | 1.19, 35.91 | 0.031 |
 Low middle | 26 | 5.29 | 2.03, 13.75 | 0.001 | 38 | 6.44 | 1.84, 22.51 | 0.004 | 41 | 3.06 | 0.65, 14.37 | 0.156 |
 Upper middle | 40 | 3.42 | 1.53, 7.66 | 0.003 | 52 | 3.23 | 0.90, 11.62 | 0.073 | 53 | 1.70 | 0.33, 8.75 | 0.525 |
 High | 76 | 1.00 | ·· |  | 87 | 1.00 | ·· |  | 88 | 1.00 | ·· |  |